相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 克隆性:
多克隆
- 供应商:
安诺伦(北京)生物科技有限公司
- 应用范围:
Cell Assay
- 靶点:
Recombinant Human 4-1BB Receptor (TNFRSF9) was expressed in E. coli cells.
- 规格:
1 mg
存储溶液:Lyophilized from 0.2 μm filtered solution in PBS (pH 7.5)
别名:Tumor necrosis factor receptor superfamily member 9, 41BB, 4-1BB ligand receptor, CDw137, T-cell antigen 4-1BB homolog, T-cell antigen ILA, CD137, Recombinant Human 4-1BB (TNFRSF9)
官网链接:https://www.signalchem.com/product_details.php?id=12806
商品关键词:4-1BB Receptor (TNFRSF9),F802-40N-1000,SignalChem
简单描述:Recombinant Human 4-1BB Receptor (TNFRSF9) was expressed in E. coli cells.
Purity: Recombinant Human 4-1BB Receptor (TNFRSF9) resolved on a 17% SDS-PAGE gel under reducing conditions and stained with Coomassie Brilliant Blue G-250
Endotoxin Level: <1.0 EU/μg of recombinant protein as determined by the LAL method
Molecular Weight: 18.0 kDa
Reconstitution Protocol: A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Sample Cell Assay Data: The ED50 as determined by dose dependent proliferation of human megakaryocytic leukemia cell line is <0.5ng/ml. br/>
官网链接: www.annoron.com
办公电话: 010-56256916
官方售后: 400-965-8633
企业QQ: 3198592576、3212874516
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人可溶性CD137 (4-1BB)ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 CD137/4-1BB/TNFRSF9 单抗包被于酶标板上,标准品和样品中的 4-1BB与单抗结合,加入生物素化的抗人 4-1BB ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入
4-1BB (CD137)/TNFRSF9 TRAIL (APO-2.L)/TNFSF10 /TL2 DR4/TNFRSF10A /TR4 &DR5/TNFRSF10B /TR7 DcR1/TNFRSF10C /TR
Non-MHC-Dependent Redirected T Cells Against Tumor Cells
. Chimeric antigen receptors are composed of the single-chain variable fragment (scFv) of a tumor-recognizing antibody cloned in frame with human T-cell signaling domains (e.g., CD3ζ, CD28, OX40, 4-1BB), thus combining the specificity of antibodies
技术资料暂无技术资料 索取技术资料






